ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,146.86
-0.21%
Dow Jones
38,589.16
-0.15%
Gold vs US Dollar
2,333.015
0.00%
Brent Oil
82.275
0.00%
Bitcoin
66,573.51
0.58%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Transkaryotic Therapies (MM) (TKTX)

  7. Transkaryotic Therapies (MM) (TKTX) News

Transkaryotic Therapies (TKTX)

Transkaryotic Therapies (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TKTX
DateTimeSourceHeadlineSymbolCompany
26/02/202021:05GlobeNewswire Inc.CRISPR Therapeutics Proposes Changes to the Board of DirectorsNASDAQ:TKTXTranskaryotic Therapies (MM)
27/07/200516:36PR Newswire (US)TKT Stockholders Approve Acquisition by ShireNASDAQ:TKTXTranskaryotic Therapies (MM)
14/07/200523:22PR Newswire (US)TKT Confirms That Board of Directors Unanimously Recommends That Stockholders Approve Shire TransactionNASDAQ:TKTXTranskaryotic Therapies (MM)
12/07/200514:01PR Newswire (US)TKT Issues Open Letter to StockholdersNASDAQ:TKTXTranskaryotic Therapies (MM)
27/06/200519:14PR Newswire (US)TKT to Hold Special Meeting of Stockholders on July 27, 2005NASDAQ:TKTXTranskaryotic Therapies (MM)
20/06/200514:01PR Newswire (US)TKT Reports Positive Top-Line Results of Hunter Syndrome Pivotal TrialNASDAQ:TKTXTranskaryotic Therapies (MM)
13/06/200514:41PR Newswire (US)TKT Announces Expiration of Both Hart-Scott-Rodino Waiting Period and SEC Review Period of Preliminary Proxy StatementNASDAQ:TKTXTranskaryotic Therapies (MM)
05/05/200514:00PR Newswire (US)TKT Announces First Quarter 2005 ResultsNASDAQ:TKTXTranskaryotic Therapies (MM)
28/04/200500:23PR Newswire (US)TKT Assessing Impact of Fire at Manufacturing FacilityNASDAQ:TKTXTranskaryotic Therapies (MM)
27/04/200522:30PR Newswire (US)TKT to Report First Quarter 2005 Financial Results on May 5, 2005NASDAQ:TKTXTranskaryotic Therapies (MM)
21/04/200515:50PR Newswire (US)TKT Announces Agreement to be Acquired by Shire for $1.6 BillionNASDAQ:TKTXTranskaryotic Therapies (MM)
20/04/200515:43PR Newswire (US)TKT Achieves GA-GCB Clinical MilestoneNASDAQ:TKTXTranskaryotic Therapies (MM)
29/03/200521:23PR Newswire (US)TKT Announces Appointment of Eric Pauwels as Senior Vice President, Global Commercial OperationsNASDAQ:TKTXTranskaryotic Therapies (MM)
28/03/200523:04PR Newswire (US)New Website Offers Comprehensive Information on Hunter SyndromeNASDAQ:TKTXTranskaryotic Therapies (MM)
24/03/200514:30PR Newswire (US)TKT to Present at Two Upcoming Healthcare ConferencesNASDAQ:TKTXTranskaryotic Therapies (MM)
17/03/200513:01PR Newswire (US)Notice to All Deutsche Bank Securities Inc. Clients From the Securities Arbitration Law Firm of Klayman & Toskes, P.A.NASDAQ:TKTXTranskaryotic Therapies (MM)
09/03/200519:21PR Newswire (US)TKT to Present at SG Cowen Securities' 25th Annual HealthCare ConferenceNASDAQ:TKTXTranskaryotic Therapies (MM)
23/02/200513:00PR Newswire (US)Strong Year of Execution Produces Solid 2004 Financial PerformanceNASDAQ:TKTXTranskaryotic Therapies (MM)
15/02/200514:31PR Newswire (US)Tamara L. Joseph Named General Counsel of TKTNASDAQ:TKTXTranskaryotic Therapies (MM)
10/02/200514:17PR Newswire (US)TKT to Report Fourth Quarter and Year-End 2004 Financial Results on February 23, 2005NASDAQ:TKTXTranskaryotic Therapies (MM)
04/02/200514:15PR Newswire (US)TKT Appoints Theresa Heggie as General Manager, EuropeNASDAQ:TKTXTranskaryotic Therapies (MM)
24/01/200520:59PR Newswire (US)Genzyme Sues to Halt TKT Gaucher TrialNASDAQ:TKTXTranskaryotic Therapies (MM)
11/01/200521:01PR Newswire (US)TKT Provides Update on Product Pipeline at JPMorgan Healthcare ConferenceNASDAQ:TKTXTranskaryotic Therapies (MM)
04/01/200515:02PR Newswire (US)TKT to Present at JPMorgan's Annual HealthCare ConferenceNASDAQ:TKTXTranskaryotic Therapies (MM)
09/12/200416:23PR Newswire (US)TKT to Present at Wachovia Biotechnology ConferenceNASDAQ:TKTXTranskaryotic Therapies (MM)
12/11/200414:15PR Newswire (US)TKT Announces Executive PromotionsNASDAQ:TKTXTranskaryotic Therapies (MM)
09/11/200413:35PR Newswire (US)TKT to Present At SG Cowen's Fifth Annual Global Health Care ConferenceNASDAQ:TKTXTranskaryotic Therapies (MM)
09/11/200413:30PR Newswire (US)TKT Reports Third Quarter 2004 Financial ResultsNASDAQ:TKTXTranskaryotic Therapies (MM)
29/10/200421:58PR Newswire (US)TKT To Report Third Quarter Financial Results On November 9, 2004NASDAQ:TKTXTranskaryotic Therapies (MM)
28/10/200423:01PR Newswire (US)TKT's Research Findings on Intrathecal Delivery of I2S Presented at ASHGNASDAQ:TKTXTranskaryotic Therapies (MM)
 Showing the most relevant articles for your search:NASDAQ:TKTX

Your Recent History

LSE
LLOY
Lloyds Banking
LSE
PANR
Pantheon Resources
LSE
GOLD
LSE
VAST
Vast Resources
LSE
BIRD
Blackbird
LSE
GKP
Gulf Keystone Petroleum
LSE
ARCM
Arc Minerals
LSE
ENET
Ethernity Networks
LSE
NEXN
Nexxen
LSE
NSCI
Netscientific
LSE
PHNX
Phoenix
LSE
EEE
Empire Metals
LSE
LGEN
Legal & General
LSE
GMET
Golden Metal Resources
LSE
SBTX
Skinbiotherapeutics
LSE
GNC
Greencore
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved